HTN II Flashcards
Primary agents
- diuretics (thiazide-type)
- ACE inhibitor
- angiotensin II receptor antagonists
- calcium channel blockers
Secondary agents
- diuretics (loop, potassium sparing, and aldosterone antagonists),
- renin inhibitor,
- sympatholytic agents (β receptor antagonists, α1 receptor antagonists, central α2-agonists)
- direct vasodilators
Clonidine (Catapres)
- MOA : a2-agonist –> reduces release of NE –> inhibit SNS
- Sympatholytic agents
- Stimulate I1 receptors –> AntiHTN
- Can also treat ADHD
- PK : lipid soluble and rapidky enters the brain
- SE : Dry mouth, sedation, rebound effect
- DDI with TCA’s
Methyldopa
- Sympatholytic agent
- Inhibits DOPA Decarbolase –> reduce Dopamin and NE
- HTN during pregnancy or gestational HTN
- Enters brain via Aromatic AA transporter
- Also cause rebound efftect
Atenolol (Tenormin) and Metoprolol (Lopressor)
- Selective β1 blockade
- advantageous in treating hypertensive patients who also suffer from asthma, diabetes, or peripheral vascular disease.
Carvedilol (Coreg), Labetalol (Trandate), and Nebivolol (Bystolic)
- β –blockade and vasodilation
- Carvedilol and labetalol are racemic mixtures that contribute to block both α and β receptors.
- Nebivolol:
- selectively blocks β1 receptors without α blockade.
- releases NO from endothelial cells and causes vasodilation.
- Carvedilol reduces mortality in patients with heart failure and is particularly useful in patients with both heart failure and hypertension.
- Labetalol: hypertensive emergencies or hypertension associated with pheochromocytoma.
Acebutolol (Sectral), Penbutolol (Levatol), and Pindolol (Visken)
- β –blockade and ISA
- partial agonists.
- They antagonize β receptors with some intrinsic sympathomimetic activity (ISA).
- beneficial for patients with bradyarrhythmias or peripheral vascular disease.
Esmolol (Brevibloc)
- β1 with shortest half-life (i.v.)
- Due to the hydrolysis of ester linkage, esmolol has the shortest half-life (9 to 10 min).
- used for management of intraoperative and postoperative hypertension as well as hypertensive emergencies.
Prazosin (Minipress), Doxazosin (Cardura), and Terazosin (Hytrin)
- Selective α1 blockade
- Alpha-Adrenoceptor-Blocking Agents
- Blocks α1 receptors in arterioles and venules⇒ dilution of both resistance and capacitance vessels.
- less reflex tachycardia when lowering blood pressure than do nonselective α antagonists
- Indicated for men with concurrent hypertension and benign prostatic hyperplasia.
- SE : orthostatis hypotension; Palpitation, headache, and dizziness.
Phentolamine (Regitine) & Phenoxybenzamine (Dibenzyline)
- Alpha-Adrenoceptor-Blocking Agents
- Non-selective α blockade
- hypertension associated with pheochromocytoma or clonidine withdraw syndrome when combing with β-blockers
Nifedipine (Adalat) or other DHPs
- Vasodilation, thus reduce arteriolar resistance by blocking L-type Ca2+ channels.
- Sustained-release form for the treatment of hypertension, angina pectoris, Raynaud’s disease, and premature labor.
- Grapefruit and other CYP3A4 inhibitors may enhance the levels of nifedipine.
- Adverse Effects: Constipation, dizzy, tachycardia, dose-related pedal edema, etc
Verapamil (Calan, Verelan) and Diltiazem (Cardizem)
- Verapamil and diltiazem are relatively selective for the myocardium calcium channels although they have both cardiac depressant and vasodilation.
- Hypertension, angina pectoris, arrhythmia
- Constipation (7.3%), dizzy, nausea, hypotension, bradycardia
- avoid routine use with beta blockers due to increased risk of bradycardia and heart block
Direct Vasodilators–ATP-dependent Potassium Channel Openers
1) . Minoxidil (Rogaine)
2) . Hydralazine (Apresoline)
Minoxidil (Rogaine)
- opening of ATP-dependent potassium channels in smooth muscle membrane.
- Hyperpolarization due to outflow of K+ stabilizes the membrane at its resting potential
- reduces the opening of voltage-dependent calcium channels
- leads to arteriolar relaxation but not veins.
- Hypertension, androgenic alopecia ( Hair Loss)
Hydralazine (Apresoline)
Opening of K+ channels
Inhibiting IP3-induced Ca2+ release from Sarcoplasmic reticulum
Release of NO from endothelium
- Severe hypertension. Certain patients have tolerance and tachyphylaxis to hydralazine.
- Reflex sympathetic activation, headache, nausea, etc. Lupus erythematosus.